诚意药业(603811.SH)：鱼油制剂的销售正在招商中，公司正在与有意向合作的企业积极洽谈中

Core Viewpoint - Chengyi Pharmaceutical (603811.SH) is preparing for the approval of its fish oil drug, expected by September 2025, which is why there are no performance data reflected in the company's semi-annual report for 2025 [1] Group 1 - The fish oil raw material is currently in the application preparation stage and has not yet received approval, thus production and sales activities have not commenced [1] - Sales of fish oil formulations are in the招商 (recruitment) phase, with the company actively negotiating with interested partner enterprises [1]